|1|Novel therapies for cutaneous T-cell lymphoma: what does the future hold? (24397291)
Guenova E.... Cozzio A.
|2|Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa. (24433874)
Vandersee S.... Beyer M.
|3|miR-223 Regulates Cell Growth and Targets Proto-Oncogenes in Mycosis Fungoides/Cutaneous T-Cell Lymphoma. (24304814)
McGirt L.Y.... Eischen C.M.
|4|Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. (23957985)
SuA!rez A.L.... Myskowski P.L.
|5|Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma. (24136145)
Illidge T.... Cowan R.
|6|Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: a systematic review. (22819279)
Schlaak M.... von Bergwelt-Baildon M.
|7|Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature. (23837676)
QuAcreux G.... DrAcno B.
|8|Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Intralesional Methotrexate Therapy. (24002114)
Yokoi I.... Kubota Y.
|9|Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma. (24307695)
Weng W.K.... Kim Y.H.
|10|Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma. (22459529)
Frye R.... Booher S.
|11|Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the I+/I^ Type with Bexarotene. (22548037)
Zhang X.... Kurschat P.
|12|Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. (22258991)
Schlaak M.... Kurschat P.
|13|Novel therapeutic agents for cutaneous T-Cell lymphoma. (22594538)
Jain S.... O'Connor O.
|14|FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type. (21154235)
Espinet B.... SolAc F.
|15|Co-infection of human herpesvirus-6 and human herpesvirus-8 in primary cutaneous diffuse large B-cell lymphoma, leg type. (21517824)
Nakayama-Ichiyama S.... Hanafusa T.
|16|Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene. (21764128)
Oliveira A.... Selores M.
|17|A case of chronic inflammatory demyelinating polyneuropathy associated with immune-mediated thrombocytopenia and cutaneous T-cell lymphoma. (21704451)
Lee J.H.... Kim S.
|18|Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). (21883142)
Wong H.K.... Porcu P.
|19|Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma. (20629661)
d'Amore F.... Hagberg H.
|20|Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab. (20542839)
Park M.Y.... Kim Y.C.
|21|A cutaneous T-cell lymphoma EORTC trials platform. (20826406)
|22|Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. (20133897)
Wozniak M.B.... Ortiz-Romero P.L.
|23|Potent topical steroids are one of the treatments for cutaneous T-cell lymphoma. (20621338)
|24|Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma. (20658231)
Kim J.S.... Yim C.Y.
|25|Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. (20212249)
Prince H.M.... Negro-Vilar A.
|26|When dead cells tell tales-cutaneous involvement by precursor T-cell acute lymphoblastic lymphoma with an uncommon phenotype. (20010405)
Yaar R.... Mahalingam M.
|27|Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome. (19558504)
Nakayama S.... Hanafusa T.
|28|Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: not always an easy task. (19548068)
Diamantidis M.D.... Hatzitolios A.
|29|Primary cutaneous diffuse large B-cell lymphoma, leg type in an elderly man with human immunodeficiency virus encephalopathy. (19734989)
Kawakami T.... Soma Y.
|30|Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. (18569636)
Golling P.... Kempf W.
|31|Primary cutaneous anaplastic large cell lymphoma successfully treated with local thermotherapy using pocket hand warmers. (19120772)
Honma M.... Iizuka H.
|32|Cutaneous T cell lymphoma: translating immunobiology into therapeutic opportunities. (18833050)
Berger C.L.... Edelson R.L.
|33|Denileukin diftitox for the treatment of cutaneous T-cell lymphoma. (19707452)
Kaminetzky D.... Hymes K.B.
|34|Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy. (18601524)
Lee T.K.... Foster T.H.
|35|Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy. (17683387)
Isogai R.... Kawada A.
|36|Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma. (17366595)
Straus D.J.... Steckel S.
|37|Advances in the treatment of primary cutaneous T-cell lymphoma. (17673888)
|38|Primary cutaneous marginal zone B-cell lymphoma of MALT type in a child. (17163787)
Dargent J.L.... Heimann P.
|39|Fusariosis occurring in an ulcerated cutaneous CD8+ T cell lymphoma tumor. (16709499)
Hsu C.K.... Lee J.Y.
|40|Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma. (16821018)
Goteri G.... Bearzi I.
|41|cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. (12839582)
Usener D.... Eichmueller S.
|42|Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. (14710892)
Kempf W.... Burg G.
|43|Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. (12006543)
Zhang C.... Duvic M.
|44|Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. (12164743)
Suchin K.R.... Rook A.H.
|45|The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation. (11407974)
Willers J.... Dummer R.
|46|Lymphoma-type adult T-cell leukaemia-lymphoma with a bulky cutaneous tumour showing multiple human T-lymphotropic virus-1 DNA integration. (11422051)
Kato N.... Mayuzumi M.
|47|Cutaneous T-cell lymphoma of the mycosis fungoides type in the area of the eyelid and lacrimal ducts]. (9206737)
Aaliouet H.... SAPnnichsen K.
|48|A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. (8668164)
Knaus P.I.... Lodish H.F.
|49|Cutaneous T-cell lymphoma, tropical spastic paraparesis, cerebral vasculitis, and protein S deficiency in a patient with HTLV-I. (8865796)
Schwartz J.... Bisaccia E.
|50|Lymphomatoid papulosis terminating as cutaneous T cell lymphoma (mycosis fungoides). (6643771)
Madison J.F.... CLENDENNING W.E.